Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
310
6 regions32 stories17 publishers13 countries
Top story
NHS approves major clinical trial on cannabis medicines and chronic pain
A clinical trial investigating the efficacy of cannabis-based medicines in up to 5,000 patients with chronic pain has been given the green light from UK regulators.
Cannabis HealthGBMedical
- 01
Cannabis industry faces fresh banking and payment hurdles
Business of CannabisUSBusiness & Investment
- 02
Cresco Labs and Columbia Care end mutual agreement plans
Business of CannabisUSBusiness & Investment
Europe
6 stories- Advocates emphasise positive effects of cannabis reform in Malta
Cannabis HealthMTRegulation
- Luxembourg implements new adult-use cannabis legalisation law not based on low-THC model
cannatechtoday.comLUAdult-use
- Bedrocan's focus on medical cannabis drives profitability, says founder
MJBizDailyNLMedical
- Cannabis distributor Cantourage expects double digit sales growth
Business of CannabisDEBusiness & Investment
- Amsterdam district committee critical of cannabis trial participation
Cannabis IndustrieNLRegulation
- MGC Pharma announces A$2.7m share purchase; Chill Brands revenues drop 87%
Business of CannabisBusiness & Investment
United States
8 stories- Illinois has some of highest-priced cannabis products in United States
Business of CannabisUSAdult-use
- New York officials close seven more cannabis stores in continuing crackdown
Business of CannabisUSAdult-use
- Adult-use cannabis sales in Maryland hit US$87.4m record in first month
Business of CannabisUSAdult-use
- Minnesota citizens can legally purchase adult-use cannabis after bill enactment
Business of CannabisUSAdult-use
- JUSTÜS Foundation receives US$100,000 for legacy cannabis operators
Business of CannabisUSBusiness & Investment
- Washington to reimburse legal fees for unconstitutional cannabis prosecutions
Business of CannabisUSRegulation
- Etain receives approval for cultivation facility in Buffalo, New York
NewswireUSBusiness & Investment
- MediPharm Labs completes CBD oils shipment to United States for clinical trial
MJBizDailyUSHealth & Science
Canada
4 stories- Village Farms International to publish second quarter 2023 results
Technical420CABusiness & Investment
- Canadian government could face class action lawsuit over cannabis legalisation
Business of CannabisCARegulation
- Ontario cannabis distributor ready to lower markups to help industry
CBCCABusiness & Investment
- Agra Ventures Ltd announces name and stock ticker symbol change on CSE
MarketScreenerCABusiness & Investment
LATAM & Caribbean
4 stories- Flora Growth announces sale of Colombian subsidiaries and assets for C$0.8m
Business of CannabisCOBusiness & Investment
- Brazilian cannabis parliamentary front opens selection for medicinal projects
SechatBRRegulation
- Uruguayan cannabis regulator releases latest adult sales data
NewsweedUYAdult-use
- Medical cannabis plant in Uruguay shuts down amid regulation concerns
buenosairesherald.comUYRegulation
Africa & Middle East
2 stories- South African policymakers recognise cannabis industry's economic growth potential
sabcnews.comZABusiness & Investment
- Israel's final draft for medical cannabis reform set to be unveiled
Cannabis Magazine (Israel)ILMedical
Oceania
4 stories- Trava Health fined A$82,500 by Therapeutic Goods Administration
CannabizAURegulation
- Cann Group to target institutional investors after capital raise shortfall
CannabizAUBusiness & Investment
- MP's reform would spare NSW drivers using medicinal cannabis from prosecution
The GuardianAUMedical
- New Zealand medical cannabis industry benefits from amended regulations
biospectrumasia.comNZRegulation
Stocks
- Weekly stock report
Business of CannabisBusiness & Investment
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report